Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 2/20 | 0.54 |
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 3/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19110600 | 0.89 | HTR7 (0.43) | HTR7HTR1AHTR2AHTR2CHTR2B | |
| SCHEMBL19110587 | 0.88 | HTR7 (0.53) | HTR7HTR1AHTR2AHTR2CHTR2B | |
| SCHEMBL19110592 | 0.86 | HTR7 (0.41) | HTR7HTR1AHTR2AHTR2CHTR2B | |
| SCHEMBL19110586 | 0.86 | SLC2A1 (0.48) | HTR7 | |
| SCHEMBL19110601 | 0.86 | ALDH1A1 (0.42) | HTR7HTR1AHTR2AHTR2CHTR2B | |
| SCHEMBL19110602 | 0.82 | CYP1A2 (0.40) | HTR7HTR1AHTR2AHTR2CHTR2B | |
| SCHEMBL17317624 | 0.80 | HTR7 (0.54) | HTR7HTR1AHTR2AHTR2CHTR2B | |
| SCHEMBL19110655 | 0.80 | HTR7 (0.43) | HTR7HTR1AHTR2AHTR2CHTR2B | |
| Hydrochloric Acid SCHEMBL19097303 | 0.79 | HTR7 (0.53) | HTR7HTR1AHTR2AHTR2CHTR2B | |
| SCHEMBL19110604 | 0.77 | HTR7 (0.33) | HTR7HTR1AHTR2AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170197960-A1 | ATX MODULATING AGENTS | BIOGEN MA INC. | 2017-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170197960-A1 | ATX MODULATING AGENTS | ENPP2, ATXN10, ATXN2 | HTR7 755/4885HTR1A 130/4885HTR2A 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.